The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With Warfarin
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00665613
: April 24, 2008
Last Update Posted
: October 14, 2015
Staten Island University Hospital
Information provided by (Responsible Party):
Mario Castellanos, North Shore Long Island Jewish Health System
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 100 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
patients on warfarintherapy in the SIUH coumadin center
Patients on warfarin that have had BMD within a year
Patients on bisphosphates, SERMS, anticonvulsants, estrogens, androgens, calcitonin, hctz and thyroid hormone replacement